The latest report by IMARC Group, titled “Cardiovascular Implants Market Report by Product Type (Coronary Stent, ICD, Heart Valve, Implanted Cardiac Pacemaker, CRT Device, Peripheral Stent), Material (Metals and Alloys, Polymers, Biological Materials), Procedure Type (Angioplasty, Open Heart Surgery), Indication (Arrhythmias, Myocardial Ischemia, Acute Myocardial Infarction, Congestive Heart Failure, and Others), and Region 2024-2032“, offers a comprehensive analysis of the industry, which comprises insights on the global cardiovascular implants market report. The global market size reached US$ 26.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 43.3 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032.
Factors Affecting the Growth of the Global Cardiovascular Implants Industry:
- Increasing Prevalence of Cardiovascular Diseases (CVDs):
The rising number of cardiovascular diseases (CVDs) is escalating the demand for cardiovascular implants. In addition, heart attacks, arrhythmias, heart failure, and stroke are common, driven by factors such as growing geriatric populations, lifestyle choices, and genetic predispositions. These conditions often require medical intervention that may include the use of various implants, such as stents to open blocked arteries, pacemakers to correct heart rhythm abnormalities, and defibrillators to prevent sudden death from arrhythmia. The necessity for these implants arises from their essential role in managing heart conditions, restoring normal cardiac function, and ultimately saving lives. As the prevalence of these diseases continues to rise, the demand for advanced, life-sustaining treatments escalates, highlighting the critical need for a improved cardiovascular implants market to meet the growing healthcare challenge.
- Emerging Technological Advancements:
The market is driven by technological innovations in cardiovascular implants, offering new hope and enhanced treatment options for patients with heart conditions. Moreover, several developments such as bioresorbable stents, which naturally dissolve in the body after healing the artery, and leadless pacemakers, which reduce the risk of infection and offer a less invasive option, represent another major growth-inducing factor. These innovations improve the safety and efficacy of cardiovascular implants, making them more compatible with the human body and reducing long-term risks associated with traditional implants. Besides this, the use of advanced materials and engineering techniques has led to the creation of devices that better mimic natural heart function, offer longer lifespans, and integrate seamlessly with patients' lifestyles. These technological advancements enhance patient outcomes and expand the potential for treatment, allowing physicians to tailor therapies more precisely to individual needs.
- Rising Healthcare Expenditure:
The increase in healthcare expenditure with the widespread adoption of advanced medical technologies, including cardiovascular implants, is contributing to the market growth. Moreover, several governments and individuals are investing more in health services, recognizing the importance of access to high-quality care in improving health outcomes and quality of life which is essential in making cutting-edge treatments, such as cardiovascular implants, more accessible to a broader population. Also, high healthcare spending facilitates the acquisition of sophisticated medical devices and supports the infrastructure required for complex procedures, enabling healthcare systems to offer advanced interventions, accelerating the market growth.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/cardiovascular-implants-market/requestsample
Competitive Landscape with Key Player:
- BIOTRONIK SE & Co. KG
- Abbott Laboratories
- AMG International
- B. Braun Melsungen AG
- Johnson & Johnson Services, Inc.
- W. L. Gore & Associates, Inc.
- Medtronic Private Limited
- Boston Scientific Corporation
- Sorin Corporation
- Edwards Lifesciences Corporation
- Fortimedix Surgical B.V.
- Neovasc Inc.
- CryoLife Inc
- Proxy Biomedical Ltd.
- REVA Medical, LLC.
- Shree Pacetronix Ltd
Report Segmentation:
The report has segmented the market into the following categories:
Product Type Insights:
- Coronary Stent
- ICD
- Heart Valve
- Implanted Cardiac Pacemaker
- CRT Device
- Peripheral Stent
Implantable cardioverter defibrillators (ICD) accounts for the largest market share due to their critical role in preventing sudden cardiac death in patients with severe heart conditions.
Material Insights:
- Metals and Alloys
- Polymers
- Biological Materials
By material, the market is classified into metals and alloys, polymers, and biological materials.
Procedure Type Insights:
- Angioplasty
- Open Heart Surgery
By procedure type, the market is classified into angioplasty and open-heart surgery.
Indication Insights:
- Arrhythmias
- Myocardial Ischemia
- Acute Myocardial Infarction
- Congestive Heart Failure
- Others
Arrhythmias are dominating the market growth due to the growing cardiovascular disorders, increasing the demand for devices that can manage irregular heartbeats effectively.
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America’s market is attributed to its advanced healthcare infrastructure, rising prevalence of cardiovascular diseases, and strong presence of leading medical device companies.
Global Cardiovascular Implants Market Trends:
At present, various innovations in implantable devices, such as miniaturization, improved battery life, and advanced monitoring capabilities, are enhancing patient outcomes and comfort making cardiovascular implants more efficient and reliable. Besides this, the increasing incidence of CVDs, driven by growing geriatric populations, sedentary lifestyles, and rising obesity rates are escalating the demand for cardiovascular implants. Besides this, the growing trend toward minimally invasive surgeries for implanting cardiovascular devices, reducing recovery time and complications patient and physician preference for these procedures. Along with this, rising healthcare expenditure, particularly in emerging economies, is enabling greater access to advanced cardiovascular treatments and implants.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel NoD) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
